Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. Due to increasing complexity in R&D, pharma teams are under pressure to drive down costs and ...

is yet more proof that this is an area on the cusp of the pharmaceutical R&D mainstream. That was one of the key messages from SynBioBeta’s Synthetic Biology Biopharma Conference last month ...

Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty ...

French immunotherapy company OSE Immunotherapeutics has appointed Dr Sonya Montgomery as chief development officer. She will ...

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare ...

10 January 2025 The US Food and Drug Administration approved 50 novel drugs in 2024, continuing to outpace its global regulatory peers.

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...

French biotech MaaT Phar­ma says its acute graft-ver­sus-host dis­ease treat­ment ex­ceed­ed ex­pec­ta­tions in a sin­gle-arm Phase 3 study in Eu­rope.

The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...

Tiwari, who serves as Senior Vice President at the world’s top asset management firm, emphasized the transformative potential ...